Attention aging baby boomers, 60ish single gentlemen, high-powered CEOs and laid-off professionals preparing for job interviews: The wait is over. Dysport, the new botulinum toxin product touted as a quicker, cheaper and longer-lasting way to banish wrinkles, has arrived. Read full story via MiamiHerald
Jun 20 2009 | Posted in
Injectables |
Read More »
A Manhattan spa is experimenting with a new, non-invasive facial procedure that gives squeamish New Yorkers an alternative to Botox injections as they try to further defy time. The Botox facial procedure begins with a light peel before active ingredients are applied to the skin then lectrical currents are then used to enhance the product’s [...]
Jun 13 2009 | Posted in
Injectables |
Read More »
Besides banishing wrinkles, Botox injections can significantly improve people’s quality of life if they suffer from another problem that increases with age, an overactive bladder (OAB). A study published in the June issue of BJU International shows that patients who had Botox injections to control bladder problems reported significant improvements in their lives as well [...]
Jun 10 2009 | Posted in
Injectables |
Read More »
Botox will have some competition in the injection cosmetics market. t wrinkle treatment. Appearance Medicine – New ZealandDysport®, a new wrinkle remover, has been approved by US Food and Drug Administration (FDA) and many experts speculate that it will be sold at a lower price than Allergan’s Botox. About Dysport Dysport is a simple, effective, [...]
Jun 10 2009 | Posted in
Injectables |
Read More »
About four months ago, Dr. Jason Shapiro, whose Fort Lauderdale practice Tribeca Medaesthetics performs cosmetic procedures such as Botox injections, cellulite reduction and laser hair removal, noticed a growing number of customers who were concerned about the cost of the confidence-boosting procedures because they were on job searches. “I feel very fortunate because our practice [...]
Jun 2 2009 | Posted in
Injectables |
Read More »
The Food and Drug Administration has sanctioned a new wrinkle-remover, Dysport, for cosmetic and therapeutic use. Like Botox, it’s an injectable drug derived from a botulinum toxin. It has been sold in Europe at a price cheaper than Botox for several years, and it is expected to be available in this country in 60 days. [...]
Jun 2 2009 | Posted in
Injectables |
Read More »
Allergan NYSE: AGN is trying to expand the use of its anti-wrinkle drug, Botox, but the Food and Drug Administration threw a wrinkle into its plan yesterday by turning down Allergan’s application to market Botox for upper limb spasticity — a disorder that causes muscles to tighten. Getting a complete response letter is rarely a [...]
May 28 2009 | Posted in
Injectables |
Read More »
Competition has arrived for Irvine-based Allergan Inc.s blockbuster wrinkle-remover Botox, but Chief Executive David Pyott plans few changes in his marketing of the drug. At the end of April, Allergan got word that it’s going to have its first domestic competitor for Botox Cosmetic when the Food and Drug Administration cleared Dysport for cosmetic and [...]
May 19 2009 | Posted in
Injectables |
Read More »
Every four to five months, Sarah Smith and her co-workers give each other a Botox treatment after a long day of work at Nuveen Cosmetic and Reconstructive Surgery in Edmond. With a quick prick of a needle, wrinkles are erased and smooth skin is visible again. Within minutes, the women are feeling refreshed and young. [...]
May 19 2009 | Posted in
Injectables |
Read More »
NEW YORK — Allergan Inc., which reported a 64% slump in first-quarter profit Friday, said it will work with the Food and Drug Administration to appropriately update labeling for its Botox and Botox cosmetic products. “We are pleased that the FDA has emphasized that the dosing units are different between the products,” Chairman and Chief [...]
May 4 2009 | Posted in
Injectables |
Read More »